Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
US Army
Federal Trade Commission
Dow
Farmers Insurance
Citi
Moodys
Argus Health
Harvard Business School

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,910,214

« Back to Dashboard

Summary for Patent: 4,910,214

Title: Optical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonist
Abstract:The separated d and l enantiomers of medetomidine and their salts are selective and potent .alpha..sub.2 -receptor agonists.
Inventor(s): Karjalainen; Arto J. (Oulu, FI), Virtanen; Raimo E. (Rusko, FI), Savolainen; Eino J. (Oulu, FI)
Assignee: Farmos Yhtyma Oy (Turku, FI)
Application Number:07/219,637
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,910,214

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8716803Jul 16, 1987

International Patent Family for Patent: 4,910,214

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece3003878► Subscribe
United Kingdom2206880► Subscribe
Cyprus1787► Subscribe
Denmark386288► Subscribe
Denmark165788► Subscribe
European Patent Office0300652► Subscribe91010Luxembourg► Subscribe
European Patent Office0300652► Subscribe300117Netherlands► Subscribe
European Patent Office0300652► SubscribeSPC/GB03/005United Kingdom► Subscribe
European Patent Office0300652► SubscribeC300117Netherlands► Subscribe
European Patent Office0300652► Subscribe2003C/005Belgium► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
AstraZeneca
Express Scripts
McKinsey
Teva
Cerilliant
Healthtrust
Chinese Patent Office
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot